About this Research Topic
Benign diseases of the colon, such as diverticular diseases and inflammatory disorders, pose significant challenges for both diagnosis and treatment. These conditions require not only precise surgical intervention but also innovative diagnostic strategies and effective management protocols. The crucial role of the gut microbiome in gastrointestinal health further complicates the strategic use of antibiotics, necessitating novel approaches to patient care.
Current diagnostic techniques must be timely and accurate to ensure effective treatment plans and surgical interventions. The integration of prognostic markers and biomarkers can substantially improve the prediction of disease severity and outcomes, offering essential guidance for surgical decisions. Surgeons, as well as other colorectal specialists, are at the forefront of implementing these advanced methodologies, striving to enhance patient outcomes.
This Research Topic aims to explore the latest advancements and cutting-edge strategies in the diagnosis, prognostic assessment, and surgical management of benign colon diseases. We seek contributions from international researchers and clinicians, including, original research articles, basic science studies, and comprehensive reviews.
Key areas of interest include, but are not limited to:
• Innovative diagnostic techniques for early and accurate detection of benign colon diseases;
• The role of prognostic markers and biomarkers in surgical planning and outcome prediction;
• Advanced surgical techniques and treatment modalities for benign colorectal disorders;
• The strategic use of antibiotics in maintaining gut microbiome health during treatment.
Through this collection, we hope to foster a multidisciplinary approach involving gastroenterologists, surgeons, and other specialists to advance the field of colorectal health and improve patient care.
Current diagnostic techniques must be timely and accurate to ensure effective treatment plans and surgical interventions. The integration of prognostic markers and biomarkers can substantially improve the prediction of disease severity and outcomes, offering essential guidance for surgical decisions. Surgeons, as well as other colorectal specialists, are at the forefront of implementing these advanced methodologies, striving to enhance patient outcomes.
This Research Topic aims to explore the latest advancements and cutting-edge strategies in the diagnosis, prognostic assessment, and surgical management of benign colon diseases. We seek contributions from international researchers and clinicians, including, original research articles, basic science studies, and comprehensive reviews.
Key areas of interest include, but are not limited to:
• Innovative diagnostic techniques for early and accurate detection of benign colon diseases;
• The role of prognostic markers and biomarkers in surgical planning and outcome prediction;
• Advanced surgical techniques and treatment modalities for benign colorectal disorders;
• The strategic use of antibiotics in maintaining gut microbiome health during treatment.
Through this collection, we hope to foster a multidisciplinary approach involving gastroenterologists, surgeons, and other specialists to advance the field of colorectal health and improve patient care.
Keywords: Benign Colon Diseases, Microbiome, Prognostic Markers, Surgical Intervention, Colorectal Health, Colorectal and Proctological Surgery
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
